Skip to main content
Clinical Trials/CTRI/2026/02/102787
CTRI/2026/02/102787Not yet recruitingPhase 2

Effectiveness Of Individualized Homoeopathic Medicine In Male Information Technology Professionals With Generalized Anxiety Disorder

JIMS Homoeopathic Medical College And Hospital1 site in 1 country38 target enrollmentStarted: March 15, 2026Last updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor
Enrollment
38
Locations
1

Study Overview

Brief Summary

This prospective interventional study aims to evaluate the effectiveness of individualized homoeopathic treatment in managing Generalized Anxiety Disorder (GAD) among male Information Technology (IT) professionals aged 25–45 years. GAD is a chronic mental health condition characterized by excessive, persistent worry accompanied by psychological and somatic symptoms, leading to significant functional impairment. Male IT professionals are particularly vulnerable due to high occupational stress, workload demands, poor work–life balance, and emerging job insecurity related to technological advancements .A total of 30 participants diagnosed with GAD as per ICD-11 and DSM-5 criteria will be enrolled. Individualized homoeopathic medicines will be prescribed based on the totality of symptoms and followed for 24 weeks. Symptom severity and treatment response will be assessed using the GAD-7 scale, while functional impact will be evaluated through the Work Productivity and Activity Impairment (WPAI) questionnaire. The study seeks to provide scientific evidence for the role of individualized homoeopathy in improving anxiety symptoms and work productivity in this high-risk population.

Study Design

Study Type
Interventional
Allocation
Na
Masking
None

Eligibility Criteria

Ages
25.00 Year(s) to 45.00 Year(s) (—)
Sex
Male

Inclusion Criteria

  • The study will include male participants aged between 25 and 45 years who are currently employed in the Information Technology sector Eligible participants must meet the diagnostic criteria for Generalized Anxiety Disorder GAD as outlined in the ICD10 and or DSM 5 Additionally they should score less than 15 on the Generalized Anxiety Disorder 7 item GAD7 scale indicating mild to moderate symptom severity Participants must also be able to understand and respond in the languages used for case taking which include Telugu English or Hindi.

Exclusion Criteria

  • Patients with other psychiatric conditions like MDD bipolar disorders psychosis schizophrenia Patients with Known Addictions and Those who are under psychiatric medications and psychotherapy.

Investigators

Sponsor
JIMS Homoeopathic Medical College And Hospital
Sponsor Class
Private medical college
Responsible Party
Principal Investigator
Principal Investigator

Dr Pendem Vishnu Bhandhavi

JIMS Homeopathic Medical College and Hospital

Study Sites (1)

Loading locations...

Similar Trials